Product Overview
BCworld Ascorbic Inj is listed for comparison with BCWORLD PHARM's Ascorbic Inj., a vitamin C injection product. The manufacturer's Korean product documentation declares ascorbic acid 500 mg/mL and a 20 mL vial presentation. These documented specifications help professional buyers identify the product, but the exact destination-market package supplied under this listing has not been confirmed. Korean formulation details below are distinguished from confirmed specifications for the supplied package.
Documented Product Features
- Vitamin C formulation: The manufacturer identifies the Korean product as a prescription vitamin C preparation containing ascorbic acid.
- Declared concentration: The Korean manufacturer-listed formulation contains ascorbic acid 500 mg/mL.
- Documented presentation: The Korean manufacturer package shows 20 mL × 10 vials; the supplied listing's pack configuration remains unconfirmed.
Composition & Specifications
| Specification | Documented information |
|---|---|
| Manufacturer product name | Ascorbic Inj. |
| Manufacturer | BCWORLD PHARM CO., LTD. |
| Product category | Prescription vitamin C preparation, as classified in the manufacturer's Korean documentation. |
| Declared active ingredient | Ascorbic acid 500 mg/mL in the Korean manufacturer-listed formulation. |
| Declared excipients | Sodium edetate hydrate, sodium hydroxide, water for injection and sodium bicarbonate in the Korean manufacturer-listed formulation. Quantities are not publicly verified. |
| Appearance | The Korean manufacturer describes a pale-yellow, clear solution in a brown vial. |
| Documented Korean package | 20 mL × 10 vials. |
| Supplied package configuration | Not publicly verified. |
| Finished-product origin for the supplied package | Not publicly verified. |
The Korean composition and package declarations do not establish identical formulation or labeling for every export-market presentation.
Product Label & Regulatory Notes
A Mongolian regulatory decision dated September 19, 2025 lists BCWORLD PHARM's Ascorbic injection in a 10 g / 20 mL, N10 presentation among newly registered imported medicines. This historical decision does not establish current registration validity or authorization in other jurisdictions. Current Korean authorization status and the destination-market authorization applicable to the supplied package have not been verified.
Frequently Asked Questions
Is the supplied listing confirmed as a ten-vial pack?
No. The manufacturer's Korean package documents 20 mL × 10 vials, but the package supplied under this listing has not been independently matched to that presentation.
Does the Korean ingredient declaration apply to every market?
Cross-market formulation equivalence has not been established. The concentration and excipient names shown here describe the Korean manufacturer-listed formulation, not a confirmed ingredient declaration for every export package.
